Local delivery of AAV2-CTLA4IgG decreases sialadenitis and improves gland function in the C57BL/6.NOD-Aec1Aec2 mouse model of Sjögren's syndrome

INTRODUCTION: Cytotoxic T-lymphocyte antigen 4 (CTLA-4) is a key negative costimulatory molecule that displays a wide range of anti-inflammatory properties and is currently approved to treat rheumatoid arthritis as a recombinant fusion protein (CTLA4IgG). To better understand the role of CTLA4IgG in...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Hongen, Nguyen, Cuong Q, Samuni, Yuval, Uede, Toshimitsu, Peck, Ammon B, Chiorini, John A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392840/
https://www.ncbi.nlm.nih.gov/pubmed/22369699
http://dx.doi.org/10.1186/ar3753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392840/
https://www.ncbi.nlm.nih.gov/pubmed/22369699
http://dx.doi.org/10.1186/ar3753

Ejemplares similares